 | Study programme 2021-2022 | Français | |
 | Pharmacochimie: études des médicaments organiques - Partie 2 | ||
Programme component of Master's in Pharmacy à la Faculty of Medicine and Pharmacy |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M1-PHARMA-009-M | Compulsory UE | BERGER Gilles |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 75 | 0 | 0 | 0 | 0 | 5 | 5.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-DOYM-022 | Pharmacochimie: études des médicaments organiques - Partie 2 | 55 | 0 | 0 | 0 | 0 | Q1 | |
| M-DOYM-080 | Etude des médicaments d'origine biologique | 20 | 0 | 0 | 0 | 0 | Q1 |
Overall mark : the assessments of each AA result in an overall mark for the UE.
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Content of UE
See both AA
Prior Experience
Chemistry, biology, biochemistry, pharmacology
Type of Assessment for UE in Q1
- Oral examination
- Written examination
Q1 UE Assessment Comments
See both AA
Type of Assessment for UE in Q3
- Oral examination
- Written examination
Method of calculating the overall mark for the Q3 UE assessment
See both AA
Q3 UE Assessment Comments
See both AA
Type of Resit Assessment for UE in Q1 (BAB1)
- Oral examination
- Written examination
Q1 UE Resit Assessment Comments (BAB1)
See above
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-DOYM-022 |
|
| M-DOYM-080 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-DOYM-022 |
|
| M-DOYM-080 |
|
Required Reading
| AA | |
|---|---|
| M-DOYM-022 | |
| M-DOYM-080 |
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-DOYM-022 | Not applicable |
| M-DOYM-080 | Powerpoint (available on Moodle) |
Recommended Reading
| AA | |
|---|---|
| M-DOYM-022 | |
| M-DOYM-080 |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-DOYM-022 | Not applicable |
| M-DOYM-080 | CBIP Analytical characterization of biotherapeutics - Wiley ; 2017 ISBN: 978-1-119-05310-1 Directive 2001/83/EC, https://ec.europa.eu/health/documents/eudralex/vol-1_fr |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-DOYM-022 | Not applicable |
| M-DOYM-080 | Not applicable |
(*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term